BIBLIOGRAPHY
This new section of the site is dedicated to articles related to fludarabine, and provides detailed and analytical information for professional use.
These scientific documents focus primarily on its use, and cover specific areas such as medical studies, the latest clinical research and new advances taking place within the pharmaceutical industry.
If you cannot find a specific article in the chronological archives below, you can use the SEARCH box situated on the left hand column.
Hematopoietic cell transplantation-comorbidity index and Karnofsky performance status are independent predictors of morbidity and mortality after allogeneic nonmyeloablative hematopoietic cell transplantation.
Cancer 2008 Feb;(): [Epub ahead of print]
High dose methylprednisolone and rituximab is an effective therapy in advanced refractory chronic lymphocytic leukemia resistant to fludarabine therapy.
Haematologica 2008 Mar;93(3):475-6
Phase I trial of nelarabine in indolent leukemias.
J Clin Oncol 2008 Mar;26(7):1098-105
Long-Term Donor-Specific Tolerance in Rat Cardiac Allografts by Intrabone Marrow Injection of Donor Bone Marrow Cells.
Transplantation 2008 Jan;85(1):93-101
Switching of donor cells after urgent second cord blood transplantation for suspected graft failure.
Int J Hematol 2007 Dec;86(5):451-4